Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Net Sales
1,403.18
1,196.42
Other Operating Income
0.00
0.00
Total Operating income
1,403.18
1,196.42
Raw Material Cost
103.51
102.29
Purchase of Finished goods
150.38
157.97
(Increase) / Decrease In Stocks
7.05
-23.74
Employee Cost
403.02
346.14
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
445.78
373.78
Total Expenditure (Excl Depreciation)
1,109.74
956.44
Operating Profit (PBDIT) excl Other Income
293.44
239.98
Other Income
10.65
5.93
Operating Profit (PBDIT)
304.09
245.91
Interest
6.97
10.60
Exceptional Items
-19.10
0.00
Gross Profit (PBDT)
278.02
235.31
Depreciation
37.87
37.16
Profit Before Tax
240.15
198.15
Tax
55.30
49.10
Provisions and contingencies
0.00
0.00
Profit After Tax
184.85
149.05
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
184.85
149.05
Share in Profit of Associates
0.27
0.38
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
185.12
149.43
Equity Capital
61.16
61.16
Face Value
10.0
10.0
Reserves
685.70
545.18
Earnings per share (EPS)
30.27
24.43
Diluted Earnings per share
30.27
24.43
Operating Profit Margin (Excl OI)
20.91%
20.06%
Gross Profit Margin
19.81%
19.67%
PAT Margin
13.19%
12.49%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 17.28%
Standalone Net Profit
YoY Growth in year ended Mar 2026 is 24.02%
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 22.28%
Interest
YoY Growth in year ended Mar 2026 is -34.25%
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Corona Remedies With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
1,403.18
0
1,403.18
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,403.18
0
1,403.18
Raw Material Cost
103.51
0
103.51
Purchase of Finished goods
150.38
0
150.38
(Increase) / Decrease In Stocks
7.05
0
7.05
Employee Cost
403.02
0
403.02
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
445.78
0.00
445.78
Total Expenditure (Excl Depreciation)
1,109.74
0
1,109.74
Operating Profit (PBDIT) excl Other Income
293.44
0.00
293.44
Other Income
10.65
0
10.65
Operating Profit (PBDIT)
304.09
0
304.09
Interest
6.97
0
6.97
Exceptional Items
-19.10
0
-19.10
Gross Profit (PBDT)
278.02
0
278.02
Depreciation
37.87
0
37.87
Profit Before Tax
240.15
0
240.15
Tax
55.30
0
55.30
Provisions and contingencies
0.00
0
0.00
Profit After Tax
184.85
0
184.85
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
184.85
0
184.85
Share in Profit of Associates
0.27
0
0.27
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
185.12
0
185.12
Equity Capital
61.16
0
61.16
Face Value
10.00
0
0.00
Reserves
685.70
0
685.70
Earnings per share (EPS)
30.27
0
30.27
Diluted Earnings per share
30.27
0
30.27
Operating Profit Margin (Excl OI)
20.91%
0%
0.00
20.91%
Gross Profit Margin
19.81%
0%
0.00
19.81%
PAT Margin
13.19%
0%
0.00
13.19%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 1,403.18 Cr
in Mar 2026Figures in Cr
Annual - Standalone Net Profit
Standalone Net Profit 184.85 Cr
in Mar 2026Figures in Cr
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 293.44 Cr
in Mar 2026Figures in Cr
Annual - Interest
Interest 6.97 Cr
in Mar 2026Figures in Cr
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.91%
in Mar 2026Figures in %






